SOMERSET, N.J., Sept. 7 /PRNewswire-FirstCall/ -- AWT, Inc. (Pink Sheets: AWTM), a distributor of state-of-the-art medical equipment to the healthcare industry, announced today an aggressive revenue growth and acquisition strategy for the next 36 months. "With the new management team and board of directors in place, the company felt it necessary to let its shareholders know of the future of their investments," stated Christopher J. Neill, CEO. Continuing his statement, "Part of our Strategy is continually researching the market for new opportunities in acquisitions, new state-of- the-art equipment, new joint ventures, or simply increasing sales. Bringing these and additional areas of business together we feel will enhance shareholder value, and for the first third of our strategy, we have identified several acquisition targets for our focus."
The Company is presently in process of closing the first of several planned and in-process acquisitions. "As we finish this first acquisition and after we implement cost controls, AWT should show an approximate 30% increase in top line revenue and a 35% increase to the bottom line net income for this particular asset. That would mean a net of $202,500 for the acquisition which would more than cover the cost of it in the first year by approximately two fold", commented Mr. Neill, CEO. Final terms are currently being negotiated and the Company hopes to close within 30 days.
"AWT's revenue growth strategy for the healthcare industry overall is about reducing costs while keeping the margins high. The premise of having a core infrastructure of state-of-the-art technologies, methodologies, or processes, is to reduce costs for the clients you are servicing. By combining both core and associated technology and processes your overall cost reduces, allowing you to service clients at a lower cost to them and a higher margin to the Company," stated Ravi Saini, Chairman of the Board.
AWT expects to add 4 more execut
'/>"/>
| SOURCE AWT, Inc. Copyright©2007 PR Newswire. All rights reserved |